Amy Swartz Ellrodt

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

Anthony A. Amato, Michael G. Hanna, Pedro Machado et al. · Neurology · 2021 · 37 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis

Sabrina Paganoni, Marc van de Rijn, Kristin Drake et al. · Muscle & Nerve · 2019 · 34 citations · Full text

Public Affairs, Health Care Management, Neurology +17

Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis

Fabiola De Marchi, James D. Berry, James Chan et al. · Journal of Neurology · 2020 · 27 citations

Life Sciences, Neurology, Neuroscience +13

Safety and activity of <scp>anti‐CD14</scp> antibody <scp>IC14</scp> (atibuclimab) in <scp>ALS</scp>: Experience with expanded access protocol

Dario Gelevski, Grace Addy, Margot Rohrer et al. · Muscle & Nerve · 2022 · 20 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Preclinical rodent toxicity studies for long term use of ceftriaxone

Elena Ratti, James D. Berry, David J. Greenblatt et al. · Toxicology Reports · 2015 · 15 citations · Full text

Pharmacy, Pharmacology, Toxicology +13